Clinical Trial: Implementing Fragmentomics Into Real World Screening IntervenTions to Evaluate Clinical Utility Among Individuals With Elevated Risk for Lung Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Lung Cancer
Study Type: INTERVENTIONAL
Official Title: Investigating the Clinical Utility of DELFI Evaluation of Lung Cancer
Brief Summary:
The purpose of this study is to determine whether availability of a DNA Evaluation of Fragments for Early Interception (DELFI) Lung Cancer Screening Test to practicing physicians affects overall lung cancer screening rates among their patients who are recommended and eligible for screening based on 2021 United States Preventive Services Task Force (USPSTF) but are not up to date with it.DELFI hypothesized that patients in the care of physicians or practice groups who have the DELFI Lung Cancer Screening Test will…
Read more